Changchun High-Tech Industry's (SHE:000661) unit, Shanghai Saizen Medical Technology, obtained a medical device registration certificate from the Shanghai Food and Drug Administration, according to a Shenzhen Stock Exchange disclosure on Thursday.
The certificate is for the biopharmaceutical company's luteinizing hormone detection kit (fluorescence immunochromatography), a kit used to detect luteinizing hormone in human urine samples.
The certificate is valid until Dec. 12, 2029, the disclosure said.
The company's shares slipped over 1% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.